135 related articles for article (PubMed ID: 38751472)
1. New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment.
Radosevic-Robin N; Kossai M; Penault-Llorca F
Transl Breast Cancer Res; 2023; 4():28. PubMed ID: 38751472
[TBL] [Abstract][Full Text] [Related]
2. HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.
Shen S; Ma W; Brown D; Da Cruz Paula A; Zhou Q; Iaosonos A; Tessier-Cloutier B; Ross DS; Troso-Sandoval T; Reis-Filho JS; Abu-Rustum N; Zhang Y; Ellenson LH; Weigelt B; Makker V; Chui MH
Mod Pathol; 2023 Nov; 36(11):100299. PubMed ID: 37558129
[TBL] [Abstract][Full Text] [Related]
3. A review on deep learning applications in highly multiplexed tissue imaging data analysis.
Zidane M; Makky A; Bruhns M; Rochwarger A; Babaei S; Claassen M; Schürch CM
Front Bioinform; 2023; 3():1159381. PubMed ID: 37564726
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
Balluff B; Hanselmann M; Heeren RM
Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
[TBL] [Abstract][Full Text] [Related]
6. Computational solutions for spatial transcriptomics.
Kleino I; Frolovaitė P; Suomi T; Elo LL
Comput Struct Biotechnol J; 2022; 20():4870-4884. PubMed ID: 36147664
[TBL] [Abstract][Full Text] [Related]
7. Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity.
Miheecheva N; Postovalova E; Lyu Y; Ramachandran A; Bagaev A; Svekolkin V; Galkin I; Zyrin V; Maximov V; Lozinsky Y; Isaev S; Ovcharov P; Shamsutdinova D; Cheng EH; Nomie K; Brown JH; Tsiper M; Ataullakhanov R; Fowler N; Hsieh JJ
Cell Rep; 2022 Aug; 40(7):111180. PubMed ID: 35977503
[TBL] [Abstract][Full Text] [Related]
8. MATISSE: a method for improved single cell segmentation in imaging mass cytometry.
Baars MJD; Sinha N; Amini M; Pieterman-Bos A; van Dam S; Ganpat MMP; Laclé MM; Oldenburg B; Vercoulen Y
BMC Biol; 2021 May; 19(1):99. PubMed ID: 33975602
[TBL] [Abstract][Full Text] [Related]
9. Imaging mass cytometry for high-dimensional tissue profiling in the eye.
Schlecht A; Boneva S; Salie H; Killmer S; Wolf J; Hajdu RI; Auw-Haedrich C; Agostini H; Reinhard T; Schlunck G; Bengsch B; Lange CA
BMC Ophthalmol; 2021 Sep; 21(1):338. PubMed ID: 34544377
[TBL] [Abstract][Full Text] [Related]
10. Navigating the cellular landscape in tissue: Recent advances in defining the pathogenesis of human disease.
Chen HY; Palendira U; Feng CG
Comput Struct Biotechnol J; 2022; 20():5256-5263. PubMed ID: 36212528
[TBL] [Abstract][Full Text] [Related]
11. Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research.
Rojas F; Hernandez S; Lazcano R; Laberiano-Fernandez C; Parra ER
Front Oncol; 2022; 12():889886. PubMed ID: 35832550
[TBL] [Abstract][Full Text] [Related]
12. [Digitalization and multiplex IHC as predictive biomarkers for novel immune-therapeutics : New challenges for immunohistochemistry].
Zielinski D
Pathologe; 2019 May; 40(3):256-263. PubMed ID: 31089796
[TBL] [Abstract][Full Text] [Related]
13. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
14. A Hitchhiker's guide to high-dimensional tissue imaging with multiplexed ion beam imaging.
Yeo YY; Cramer P; Deisher A; Bai Y; Zhu B; Yeo WJ; Shipp MA; Rodig SJ; Jiang S
Methods Cell Biol; 2024; 186():213-231. PubMed ID: 38705600
[TBL] [Abstract][Full Text] [Related]
15. A novel process for H&E, immunofluorescence, and imaging mass cytometry on a single slide with a concise analytics pipeline.
Marlin MC; Stephens T; Wright C; Smith M; Wright K; Guthridge JM
Cytometry A; 2023 Dec; 103(12):1010-1018. PubMed ID: 37724720
[TBL] [Abstract][Full Text] [Related]
16. High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research.
Beechem JM
Methods Mol Biol; 2020; 2055():563-583. PubMed ID: 31502169
[TBL] [Abstract][Full Text] [Related]
17. Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting.
Devine RD; Behbehani GK
Clin Lab Med; 2021 Jun; 41(2):297-308. PubMed ID: 34020765
[TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
[TBL] [Abstract][Full Text] [Related]
19. Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.
da Costa JB; Gibb EA; Nykopp TK; Mannas M; Wyatt AW; Black PC
Urol Oncol; 2022 Jul; 40(7):287-294. PubMed ID: 30528886
[TBL] [Abstract][Full Text] [Related]
20. Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody.
Song X; Xiong A; Wu F; Li X; Wang J; Jiang T; Chen P; Zhang X; Zhao Z; Liu H; Cheng L; Zhao C; Wang Z; Pan C; Cui X; Xu T; Luo H; Zhou C
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36854570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
